However, the effectiveness of adoptive T cell therapies could be hindered by the TNF-α-induced reversible loss of melanoma-associated antigens, which promoted melanoma plasticity and led to the appearance of resistant, dedifferentiated cancer cells [56]. The gene discussed is TNF; the disease is melanoma.